<p>Western blot analysis of pAkt and Akt in non-differentiated (St-T1, first line; KdS1, second line) and decidualized (dSt-T1, third line; dKdS1, fourth line) ESCs after treatments with F 15min, IITT 15min and IITT 24h + F 15min vs. untreated controls. (A) Representative blot of pAkt (60kDa), Akt (60kDa) and β-Actin (42kDa) as loading control. (B) Pixel densitiy evaluation of pAkt normalized to Akt is given as mean±SEM of n = 6 independent experiments, *p<0.05 wildtype vs. Sdc-1 kd cells, #p<0.05 undifferentiated vs. decidualized cells, ✝p<0.05 untreated control vs. treated.</p
<p>Western blot for (A) pAKT (Ser473, 60 kDa) and total AKT (60 kDa), (B) pPDGFRA (195 kDa) and tota...
<p><i>A</i>, effect of Akt knockdown on cell proliferation. T47D cells were plated at 6×10<sup>5</su...
<p>Analysis of Caspase-8 and -9 activation of treated cells vs. untreated controls in non-differenti...
<p>Western blot analysis of pJNK and JNK in non-differentiated (St-T1, first line; KdS1, second line...
<p>Western blot analysis of NFκB members p65 and IκBα in non-differentiated (St-T1, first line; KdS1...
<p>A549 cells were untreated or treated with 500 nM of 1, 9, 12, 16, 32, 33, and 35 for 24 h. Follow...
<p>Representative immunoblots and densitometric analysis of (A) phosphorylated Akt (p-Akt) and total...
<p>(A) MCF7 cells were treated with 1 µmol/L CG0009 and analyzed by immunoblotting with anti-pAKT<su...
<p>(A) PC-3 cells were incubated in the absence or presence of reevesioside A (50 nM) for various ti...
<p>A. Analysis of serum-stimulated phosphorylation of AKT and ERK1/2 as well as total AKT and ERK1/2...
<p>(A) p-Akt and Akt proteins of SW620 group and SW480 group were performed by western blotting anal...
<p>Cells were pre-treated with NO-Cbl (300 µM, 16 h) followed by doxorubicin (20 µM, 4 h) or cisplat...
<p>•<b>) as determined by Western blotting.</b> A representative immunoblot of p-Akt<sup>T308</sup> ...
<p>SK-HEP1 liver cancer cells were treated with (at 0.5 mg/ml) or without AcFBE for 2 or 4 hrs. Immu...
<p>Antibody array analysis of apoptosis-related proteins in ESCs of (A) untreated, non-differentiate...
<p>Western blot for (A) pAKT (Ser473, 60 kDa) and total AKT (60 kDa), (B) pPDGFRA (195 kDa) and tota...
<p><i>A</i>, effect of Akt knockdown on cell proliferation. T47D cells were plated at 6×10<sup>5</su...
<p>Analysis of Caspase-8 and -9 activation of treated cells vs. untreated controls in non-differenti...
<p>Western blot analysis of pJNK and JNK in non-differentiated (St-T1, first line; KdS1, second line...
<p>Western blot analysis of NFκB members p65 and IκBα in non-differentiated (St-T1, first line; KdS1...
<p>A549 cells were untreated or treated with 500 nM of 1, 9, 12, 16, 32, 33, and 35 for 24 h. Follow...
<p>Representative immunoblots and densitometric analysis of (A) phosphorylated Akt (p-Akt) and total...
<p>(A) MCF7 cells were treated with 1 µmol/L CG0009 and analyzed by immunoblotting with anti-pAKT<su...
<p>(A) PC-3 cells were incubated in the absence or presence of reevesioside A (50 nM) for various ti...
<p>A. Analysis of serum-stimulated phosphorylation of AKT and ERK1/2 as well as total AKT and ERK1/2...
<p>(A) p-Akt and Akt proteins of SW620 group and SW480 group were performed by western blotting anal...
<p>Cells were pre-treated with NO-Cbl (300 µM, 16 h) followed by doxorubicin (20 µM, 4 h) or cisplat...
<p>•<b>) as determined by Western blotting.</b> A representative immunoblot of p-Akt<sup>T308</sup> ...
<p>SK-HEP1 liver cancer cells were treated with (at 0.5 mg/ml) or without AcFBE for 2 or 4 hrs. Immu...
<p>Antibody array analysis of apoptosis-related proteins in ESCs of (A) untreated, non-differentiate...
<p>Western blot for (A) pAKT (Ser473, 60 kDa) and total AKT (60 kDa), (B) pPDGFRA (195 kDa) and tota...
<p><i>A</i>, effect of Akt knockdown on cell proliferation. T47D cells were plated at 6×10<sup>5</su...
<p>Analysis of Caspase-8 and -9 activation of treated cells vs. untreated controls in non-differenti...